Cutaneous mucormycosis in a chronic lymphocytic leukemia patient on ibrutinib
Sign Up to like & getrecommendations! Published in 2021 at "IDCases"
DOI: 10.1016/j.idcr.2021.e01120
Abstract: Highlights • Mucorales known to cause opportunistic infections in immunocompromised hosts.• This is the 2nd reported case of cutaneous mucormycosis in a patient on ibrutinib.• Amphotericin B is typical 1st line therapy.• We report successful… read more here.
Keywords: mucormycosis chronic; mucormycosis; patient ibrutinib; cutaneous mucormycosis ... See more keywords